Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes

Emmy D.G. Fleuren(Cancer Institute of New South Wales), Roger J. Daly(Discovery Institute)
Cancer Research
June 20, 2017
Cited by 35


Related Papers